Test Price
2,800 AED✅ Home Collection Available
GAN Gene (Giant Axonal Neuropathy Type 1) Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- 99.9% Diagnostic Sensitivity –
ISO 9001:2015‑certified processing guarantees clinical‑grade accuracy for GAN variant detection. - VIP Mobile Phlebotomy – DHA‑licensed phlebotomists perform hospital‑grade blood sampling in sterile, cold‑chain conditions (8 AM–11 PM, daily).
- Telephonic Post‑Test Clinical Guidance – Complimentary result interpretation with a clinical geneticist (appointment required).
- Direct Billing Verification – WhatsApp +971 54 548 8731 for instant insurance pre‑approval check.
Test Overview & Methodology
This test uses Next‑Generation Sequencing (NGS) to analyse the entire coding region of the GAN gene, detecting pathogenic variants causative of Giant Axonal Neuropathy type 1. Designed for UAE patients and referring specialists, it provides a definitive molecular diagnosis within 3–4 weeks, enabling targeted neurological management and family planning.
| Feature | Our Test (Precision Panel) | Traditional Single‑Gene Sanger |
|---|---|---|
| Methodology | NGS (100× average depth) with Sanger confirmation | Sanger sequencing only |
| Analytical Sensitivity | >99.9% for SNVs & small indels | ~95% for targeted variants |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Result Report | ACMG‑compliant with clinical interpretation | Basic variant list only |
Physician Insight & Safety Protocols
“A positive GAN test must always be integrated with clinical and electrophysiological findings. Negative results do not exclude the condition if symptom onset is early or atypical, and informed genetic counselling is non‑negotiable.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License 9294403
Advisory Notice
⚠️ Do not discontinue or adjust prescribed medication without consulting your neurologist. This genetic test is diagnostic, not therapeutic.
Exclusion Criteria
- Minors (<18 years) must have parental/guardian consent as per UAE Federal Law.
- Severe coagulopathy or active anticoagulation that cannot be safely paused for venipuncture.
- Inability to undergo informed genetic counselling (cognitive impairment without a legal representative).
Emergency Red Flags – Seek Immediate Care
- Acute‑onset limb weakness, respiratory difficulty, or dysphagia.
- Sudden vision loss or unexplained seizures.
- Severe pain unresponsive to standard analgesics.
Patient FAQ & Clinical Guidance
1. What does the GAN gene test detect?
The GAN gene test analyses the GAN gene for disease‑causing mutations that lead to giant axonal neuropathy type 1 using next‑generation sequencing. It determines if a patient carries biallelic or monoallelic variants, confirming the diagnosis or carrier status.
2. How is the sample collected?
A certified phlebotomist draws a small amount of blood (EDTA tube) or a dried blood spot, ensuring cold‑chain transport to our ISO‑accredited laboratory. Painless at‑home service is available daily from 8 AM–11 PM.
3. When will I receive my results and what do they include?
Results are delivered within 3–4 weeks in a comprehensive report containing variant nomenclature, ACMG classification, and a clinical interpretation for your treating neurologist. Urgent requests can be prioritised upon physician’s note.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Legal Compliance
This service strictly adheres to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted and stored on local servers inside UAE sovereign boundaries. Laboratory facility license: DHA 1143.
For clinical appointments or home collection, contact +971 54 548 8731 (WhatsApp).
Clinical & Logistical Metadata
| Test Name | GAN Gene (Giant Axonal Neuropathy Type 1) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA) or Dried Blood Spot |
| Methodology Used | Next‑Generation Sequencing (NGS) with Sanger Confirmation |
| ICD‑10‑CM Code | G60.8 |
| LOINC Code | 82810-3 |
| DHA Facility License & Address | License 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians